Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2003-3-7
pubmed:abstractText
The prognosis for patients with malignant astrocytoma or brain metastases is often fatal despite intensive therapy. Therefore we wished to elucidate whether the quality of life (QoL) is a determinant of overall survival (OAS).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0378-584X
pubmed:author
pubmed:copyrightInfo
Copyright 2003 S. Karger GmbH, Freiburg
pubmed:issnType
Print
pubmed:volume
26
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
38-43
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:12624516-Adult, pubmed-meshheading:12624516-Aged, pubmed-meshheading:12624516-Aged, 80 and over, pubmed-meshheading:12624516-Astrocytoma, pubmed-meshheading:12624516-Brain Neoplasms, pubmed-meshheading:12624516-Cranial Irradiation, pubmed-meshheading:12624516-Female, pubmed-meshheading:12624516-Follow-Up Studies, pubmed-meshheading:12624516-Glioblastoma, pubmed-meshheading:12624516-Humans, pubmed-meshheading:12624516-Male, pubmed-meshheading:12624516-Marital Status, pubmed-meshheading:12624516-Middle Aged, pubmed-meshheading:12624516-Outcome Assessment (Health Care), pubmed-meshheading:12624516-Prognosis, pubmed-meshheading:12624516-Quality of Life, pubmed-meshheading:12624516-Radiotherapy, Adjuvant, pubmed-meshheading:12624516-Regression Analysis, pubmed-meshheading:12624516-Risk Assessment, pubmed-meshheading:12624516-Survival Rate
pubmed:year
2003
pubmed:articleTitle
Quality of life (QoL) as predictive mediator variable for survival in patients with intracerebral neoplasma during radiotherapy.
pubmed:affiliation
Department of Radiotherapy and Radiooncology, Klinikum Grosshadern, Ludwig Maximilians University, Munich, Germany. susanne.sehlen@helios.med.uni-muenchen.de
pubmed:publicationType
Journal Article